CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies

Lv Kaosheng, Jing Jiang, Ryan Donaghy, Christopher R. Riling, Ying Cheng, Vemika Chandra, Krasimira Rozenova, Wei An, Bhopal C. Mohapatra, Benjamin T. Goetz, Vinodh Pillai, Xu Han, Emily A. Todd, Grace R. Jeschke, Wallace Y. Langdon, Suresh Kumar, Elizabeth O. Hexner, Hamid Band, Wei Tong

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Janus kinase 2 (JAK2) is a central kinase in hematopoietic stem/progenitor cells (HSPCs), and its uncontrolled activation is a prominent oncogenic driver of hematopoietic neoplasms. However, molecular mechanisms underlying the regulation of JAK2 have remained elusive. Here we report that the Casitas B-cell lymphoma (CBL) family E3 ubiquitin ligases down-regulate JAK2 stability and signaling via the adaptor protein LNK/SH2B3. We demonstrated that depletion of CBL/CBL-B or LNK abrogated JAK2 ubiquitination, extended JAK2 half-life, and enhanced JAK2 signaling and cell growth in human cell lines as well as primary murine HSPCs. Built on these findings, we showed that JAK inhibitor (JAKi) significantly reduced aberrant HSPCs and mitigated leukemia development in a mouse model of aggressive myeloid leukemia driven by loss of Cbl and Cbl-b. Importantly, primary human CBL mutated (CBLmut) leukemias exhibited increased JAK2 protein levels and signaling and were hypersensitive to JAKi. Loss-offunction mutations in CBL E3 ubiquitin ligases are found in a wide range of myeloid malignancies, which are diseases without effective treatment options. Hence, our studies reveal a novel signaling axis that regulates JAK2 in normal and malignant HSPCs and suggest new therapeutic strategies for treating CBLmut myeloid malignancies.

Original languageEnglish (US)
Pages (from-to)1007-1023
Number of pages17
JournalGenes and Development
Issue number10
StatePublished - May 15 2017


  • Acute myeloid leukemia (AML)
  • Chronic myelomonocytic leukemia (CMML)
  • Hematopoietic stem cells (HSCs)
  • Janus kinase 2 (JAK2)
  • Juvenile myelomonocytic leukemia (JMML)
  • Signaling
  • Ubiquitin

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology


Dive into the research topics of 'CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies'. Together they form a unique fingerprint.

Cite this